Responses
Epidemiology and outcomes
Clinical, laboratory and health-related quality of life correlates of Systemic Lupus Erythematosus Responder Index response: a post hoc analysis of the phase 3 belimumab trials
Compose a Response to This Article
Other responses
No responses have been published for this article.